Surgery – Respiratory method or device – Combined with or convertible to a nonrespiratory device – or...
Reexamination Certificate
2003-12-12
2010-06-15
Richter, Johann R (Department: 1616)
Surgery
Respiratory method or device
Combined with or convertible to a nonrespiratory device, or...
C424S489000, C424S046000, C514S002600
Reexamination Certificate
active
07735485
ABSTRACT:
A dry powder inhalation system suitable for transpulmonary administration. The dry powder inhalation system is characterized by using a combination of:(1) a vessel housing a freeze-dried composition prepared by freeze-drying a composition liquid containing ingredients in a non-dissolved form, and has:(i) a non-powder cake-like form,(ii) a disintegration index of 0.05 or more, and(iii) a property of becoming fine particles having a mean particle diameter (mass median aerodynamic diameter) of 10 microns or less or a fine particle fraction of 10% or more upon receipt of an air impact having an air speed of at least 1 m/sec and an air flow rate of at least 17 ml/sec; and(2) a device comprising a member capable of applying the air impact to the freeze-dried composition in said vessel, and a member for discharging the powder-form freeze-dried composition that has been made into fine particles.
REFERENCES:
patent: 1950926 (1934-03-01), Lobl
patent: 3874381 (1975-04-01), Baum
patent: 4064878 (1977-12-01), Lundquist
patent: 4940662 (1990-07-01), Yamazaki et al.
patent: 4992419 (1991-02-01), Woog et al.
patent: 5044091 (1991-09-01), Ueda et al.
patent: 5326753 (1994-07-01), Ohtsuki et al.
patent: 5349947 (1994-09-01), Newhouse et al.
patent: 5354934 (1994-10-01), Pitt et al.
patent: 5503144 (1996-04-01), Bacon
patent: 5533502 (1996-07-01), Piper
patent: 5654007 (1997-08-01), Johnson et al.
patent: 5752505 (1998-05-01), Ohki et al.
patent: 5785049 (1998-07-01), Smith et al.
patent: 5826633 (1998-10-01), Parks et al.
patent: 5875776 (1999-03-01), Vaghefi
patent: 5889202 (1999-03-01), Alapati et al.
patent: 5954047 (1999-09-01), Armer et al.
patent: 5964416 (1999-10-01), Jaeger et al.
patent: 5996577 (1999-12-01), Ohki et al.
patent: 6153224 (2000-11-01), Staniforth
patent: 6186141 (2001-02-01), Pike et al.
patent: 6231851 (2001-05-01), Plantz et al.
patent: 6284282 (2001-09-01), Maa et al.
patent: 6394085 (2002-05-01), Hardy et al.
patent: 6402055 (2002-06-01), Jaeger et al.
patent: 6461591 (2002-10-01), Keller et al.
patent: 6497373 (2002-12-01), Jaeger et al.
patent: 6503537 (2003-01-01), Yang
patent: 6726124 (2004-04-01), Jaeger et al.
patent: 2003/0101995 (2003-06-01), Yamashita et al.
patent: 2003/0138402 (2003-07-01), Yamashita et al.
patent: 0133 767 (1985-03-01), None
patent: 0168 008 (1986-01-01), None
patent: 0360340 (1990-03-01), None
patent: 0407276 (1991-01-01), None
patent: 0437 622 (1991-07-01), None
patent: 0578 823 (1994-01-01), None
patent: 0709 085 (1996-05-01), None
patent: 1080720 (2001-03-01), None
patent: 204993 (1992-03-01), None
patent: 205857 (1992-07-01), None
patent: 216770 (1999-08-01), None
patent: 221232 (2002-08-01), None
patent: 60-52847 (1985-04-01), None
patent: 3-131271 (1991-06-01), None
patent: 06-321805 (1994-11-01), None
patent: 8-103499 (1996-04-01), None
patent: 11-171760 (1999-06-01), None
patent: 2001-151673 (2001-06-01), None
patent: WO 84/02274 (1984-06-01), None
patent: WO 91/16038 (1991-10-01), None
patent: WO 94/14492 (1994-07-01), None
patent: WO 94/28876 (1994-12-01), None
patent: WO 95/31479 (1995-11-01), None
patent: WO 96/32149 (1996-10-01), None
patent: WO 96/40068 (1996-12-01), None
patent: WO 97/23239 (1997-07-01), None
patent: WO 99/17754 (1999-04-01), None
patent: WO 00/15263 (2000-03-01), None
patent: WO 00/24444 (2000-05-01), None
G. Slama et al., “A new non-invasive method for treating insulin-reaction: intranasal lyophilized glucagons,”Diabetologia, 33:671-674 (1990).
P. Lucas et al., “Protein Deposition from Dry Powder Inhalers: Fine Particle Multiplets as Performance Modifiers,” Pharmaceutical Research, vol. 15, No. 4, pp. 562-569 (New York, Plenum Publishing Corp., 1998).
U. Conte et al., “Spray Dried Microsphere Preparation: Influence of the Technological Parameters,” Drug Development and Industrial Pharmacy, vol. 20, No. 3, pp. 235-258 (New York, Marcel Dekker, Inc., 1994).
K. Inazu & K. Shima, “Freeze-Drying and Quality Evaluation of Protein Drugs,” Developments in Biological Standardization, vol. 74, pp. 307-322 (Basel, Switzerland, Karger AG, 1991).
“Aerosol Powder Device,” A partial translation of Nippon Rinsho, vol. 56, No. 3 (Mar. 1998) p. 212 (764) left col. L6—p. 215 (767) left col. L25.
Pending Claims for U.S. Appl. No. 10/170,339.
Supplementary European Search Report, Appln. No./Patent No. 03778863.5-2114 / 1579855 PCT/JP0315931, Oct. 15, 2009.
Akagi Akitsuna
Fukunaga Yuichiro
Yamashita Chikamasa
Acevedo James H Alstrum
Finnegan Henderson Farabow Garrett & Dunner L.L.P.
Otsuka Pharmaceutical Co. Ltd.
Richter Johann R
LandOfFree
Dry powder inhalation system for transpulmonary administration does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dry powder inhalation system for transpulmonary administration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dry powder inhalation system for transpulmonary administration will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4164716